Important update: Healthcare facilities
CDC has updated select ways to operate healthcare systems effectively in response to COVID-19 vaccination. Learn more
UPDATE
Given new evidence on the B.1.617.2 (Delta) variant, CDC has updated the guidance for fully vaccinated people. CDC recommends universal indoor masking for all teachers, staff, students, and visitors to K-12 schools, regardless of vaccination status. Children should return to full-time in-person learning in the fall with layered prevention strategies in place.
UPDATE
The White House announced that vaccines will be required for international travelers coming into the United States, with an effective date of November 8, 2021. For purposes of entry into the United States, vaccines accepted will include FDA approved or authorized and WHO Emergency Use Listing vaccines. More information is available here.

SARS-CoV-2 Variant Classifications and Definitions

SARS-CoV-2 Variant Classifications and Definitions
Updated Sept. 1, 2023

What You Need to Know

  • Viruses like SARS-CoV-2 continuously evolve as changes in the genetic code (caused by genetic mutations or viral recombination) occur during replication of the genome.
  • SARS-CoV-2 has consistently mutated over the course of the pandemic, resulting in variants that are different from the original SARS-CoV-2 virus.
  • Throughout the COVID-19 pandemic, many variants of SARS-CoV-2 have been found in the United States and globally.
  • Scientists use multiple classification systems to describe and communicate similarities and differences between SARS-CoV-2 viruses.

Key Definitions

  • Mutation: A mutation refers to a single change in a virus’s genome (genetic code). Mutations happen frequently, but only sometimes change the characteristics of the virus.
  • Lineage: A lineage is a group of closely related viruses with a common ancestor. SARS-CoV-2 has many lineages; all cause COVID-19.
  • Sublineage: A term used to define a lineage as it relates to being a direct descendent of a parent lineage. For example, BA.2.75 is a sublineage of BA.2.
  • Variant: A variant is a viral genome (genetic code) that may contain one or more mutations. In some cases, a lineage or group of lineages with similar genetic changes, may be designated by the World Health Organization (WHO) or the U.S. SARS-CoV-2 Interagency Group (SIG) as a Variant of Interest (VOI), Variant of Concern (VOC), Variant of High Consequence (VOHC) or Variant Being Monitored (VBM) due to shared attributes and characteristics that may require public health action.
  • Recombination: A process in which the genomes of two SARS-CoV-2 variants combine during the viral replication process to form a new variant that is different from both parent lineages. This may occur when a person is infected with two variants at the same time. The lineage that results from recombination is called a “recombinant.”

Types of Classification

There are multiple ways in which SARS-CoV-2 viruses are classified. Each classification type can be appropriate, depending on the context in which SARS-CoV-2 is being communicated. SARS-CoV-2 is often discussed in the context of lineages (and sublineages). The most commonly used classification system for lineages is Pango. Nextclade may also be used in this context. In a larger context, lineages or groups of related lineages may be classified using Greek letters (such as Omicron) by the World Health Organization (WHO). These classification methods enable scientists to communicate similarities and differences between SARS-CoV-2 viruses.

Variant Classification

The U.S. Department of Health and Human Services (HHS) established a SARS-CoV-2 Interagency Group (SIG) to enhance coordination among CDC, National Institutes of Health (NIH), Food and Drug Administration (FDA), Biomedical Advanced Research and Development Authority (BARDA), and Department of Defense (DoD). This interagency group characterizes emerging variants and monitors their potential impact on vaccines, therapeutics, and diagnostics.

The SIG meets regularly to evaluate SARS-CoV-2 variants and lineages circulating in the United States and to make recommendations about the classification of variants and lineages. A group of experts assess the available data on variant proportion at the national and regional level. This information is shared with local and state public health officials to aid in their decision-making for community-level guidance. They also assess how these changes may affect vaccines, therapeutics, and diagnostics, as well as transmission and severity of disease. Variants may be reclassified as more information becomes available.

The SIG has updated its classification system and working definitions for variants of SARS-CoV-2, the virus that causes COVID-19, to better reflect the current variant landscape. The previous system classified all Omicron sublineages as part of the Omicron VOC and therefore did not provide the distinction needed to compare new descendent lineages with altered phenotypic characteristics to the Omicron parent lineages (BA.1, BA.2). These classification updates allow for independent evaluation and tracking of Omicron sublineages and forthcoming new variants when required.

The SIG uses four types of classifications:

  • Variant of high consequence (VOHC)
  • Variant of concern (VOC)
  • Variant of interest (VOI)
  • Variants being monitored (VBM)

Notes: Each variant classification includes the possible attributes of lower classes (for example, VOC includes the possible attributes of VOI). This page will be updated as needed to show the variants that belong to each class. U.S. classifications may differ from the WHO classifications because the impact of variants may differ by location. The labels assigned to each variant are provided in the List of Variants Table.

Pango Lineage System

The Pango lineage system is hierarchical—like a family tree. Lineages are evolutionarily descendants of a “parent” lineage. A lineage may be described as a “sublineage” when it is being discussed in relation to its parent lineage.

Lineages are named using an alphabetical prefix (such as B or BA) and numerical suffix (such as “.1” or “.1.1.5”). When a new lineage is defined, the Pango system assigns an additional number to the name of its parent lineage (e.g., BA.2.75 is a sublineage of BA.2). As the virus continues to change, the Pango lineage names can become very long. Lineages with longer names may be given alphabetic aliases and numbering continues (e.g., “BA” stands for “B.1.1.529,” thus BA.2 is the same as B.1.1.529.2).

For more information on the Pango lineage system and its nomenclature, see the Pango Network. For a full list of the current Pango lineages, see cov-lineages.org.

Nextclade

Nextclade is a tool that is used to classify SARS-CoV-2 sequences according to their genetic relatedness. Potentially important branches of the SARS-CoV-2 family tree are given names, indicating members of that branch are a “clade” and are thought to arise from a common ancestor.

Members of a clade will share many features with each other, reflecting their common ancestry.  Not every SARS-CoV-2 virus is assigned its own clade by Nextclade. Each potential clade must circulate at a certain frequency for a period of time, show consistent growth in a region, or be assigned a WHO classification. The Nextclade team outlines their clade designation rubric in this publication. These broader definitions offer an alternative naming solution that is meant to reflect significant differences in biology or circulation.

Nextclade clade names consist of the two-digit year of assignment followed by a letter indicating the order of assignment within the year. For example, “22A” is the first clade designated in 2022 and corresponds to the group of Pango lineages that descended from BA.4, which was circulating in early 2022. More information about the various clades and their relationship to the various Pango lineages is detailed at covariants.org.

Recombinants

All coronaviruses have the potential to undergo a natural process called “recombination”. This can occur when two different lineages infect the same cell in someone at the same time. This rare phenomenon may affect the characteristics of the virus – including its ability to spread, cause severe disease or make treatments or vaccines less effective. In many cases, recombinant viruses do not have competitive advantages that help them rise.

CDC’s genomic surveillance systems can reliably detect and monitor the spread of variants, including recombinants.  When a recombinant does emerge, CDC scientists evaluate and monitor the new recombinant just like any other variant lineage – including how it might be classified or when it should be presented on CDC’s COVID Data Tracker.

Summary of Variant Classifications

List of Variants

WHO Label

WHO Label

WHO Label

Pango Lineage

Pango Lineage

Pango Lineage

Current Status

Current Status

Current Status

Date of Designation

Date of Designation

Date of Designation

N/A

WHO Label

N/A

Variants containing the F456L spike mutations*

Pango Lineage

Variants containing the F456L spike mutations*

VOI

Current Status

VOI

VOI: September 1, 2023

Date of Designation

VOI: September 1, 2023

Omicron

WHO Label

Omicron

BA.2.86

Pango Lineage

BA.2.86

VBM

Current Status

VBM

VBM: September 1, 2023

Date of Designation

VBM: September 1, 2023

Omicron

WHO Label

Omicron

XBB.1.9.1

Pango Lineage

XBB.1.9.1

VBM

Current Status

VBM

VBM: September 1, 2023

Date of Designation

VBM: September 1, 2023

Omicron

WHO Label

Omicron

XBB.1.9.2

Pango Lineage

XBB.1.9.2

VBM

Current Status

VBM

VBM: September 1, 2023

Date of Designation

VBM: September 1, 2023

Omicron

WHO Label

Omicron

XBB.2.3

Pango Lineage

XBB.2.3

VBM

Current Status

VBM

VBM: September 1, 2023

Date of Designation

VBM: September 1, 2023

Omicron

WHO Label

Omicron

XBB.1.16

Pango Lineage

XBB.1.16

VBM

Current Status

VBM

VBM: September 1, 2023

Date of Designation

VBM: September 1, 2023

Omicron

WHO Label

Omicron

XBB.1.5

Pango Lineage

XBB.1.5

VBM

Current Status

VBM

VBM: September 1, 2023

Date of Designation

VBM: September 1, 2023

Omicron

WHO Label

Omicron

CH.1.1

Pango Lineage

CH.1.1

VBM

Current Status

VBM

VBM: September 1, 2023

Date of Designation

VBM: September 1, 2023

Omicron

WHO Label

Omicron

BA.2.74

Pango Lineage

BA.2.74

VBM

Current Status

VBM

VBM: September 1, 2023

Date of Designation

VBM: September 1, 2023

Alpha

WHO Label

Alpha

B.1.1.7 and Q lineages

Pango Lineage

B.1.1.7 and Q lineages

VBM

Current Status

VBM

VOC: December 29, 2020

VBM: September 21, 2021

Date of Designation

VOC: December 29, 2020

VBM: September 21, 2021

Beta

WHO Label

Beta

B.1.351 and descendent lineages

Pango Lineage

B.1.351 and descendent lineages

VBM

Current Status

VBM

VOC:  December 29, 2020

VBM: September 21, 2021

Date of Designation

VOC:  December 29, 2020

VBM: September 21, 2021

Gamma

WHO Label

Gamma

P.1 and descendent lineages

Pango Lineage

P.1 and descendent lineages

VBM

Current Status

VBM

VOC:  December 29, 2020

VBM: September 21, 2021

Date of Designation

VOC:  December 29, 2020

VBM: September 21, 2021

Delta

WHO Label

Delta

B.1.617.2 and descendant lineages

Pango Lineage

B.1.617.2 and descendant lineages

VBM

Current Status

VBM

VOC: June 15, 2021

VBM: April 14, 2022

Date of Designation

VOC: June 15, 2021

VBM: April 14, 2022

Epsilon

WHO Label

Epsilon

B.1.427 and
B.1.429

Pango Lineage

B.1.427 and
B.1.429

VBM

Current Status

VBM

VOC:  March 19, 2021

VOI:  February 26, 2021

VOI: June 29, 2021

VBM: September 21, 2021

Date of Designation

VOC:  March 19, 2021

VOI:  February 26, 2021

VOI: June 29, 2021

VBM: September 21, 2021

Eta

WHO Label

Eta

B.1.525

Pango Lineage

B.1.525

VBM

Current Status

VBM

VOI:  February 26, 2021

VBM: September 21, 2021

Date of Designation

VOI:  February 26, 2021

VBM: September 21, 2021

Iota

WHO Label

Iota

B.1.526

Pango Lineage

B.1.526

VBM

Current Status

VBM

VOI:  February 26, 2021

VBM: September 21, 2021

Date of Designation

VOI:  February 26, 2021

VBM: September 21, 2021

Kappa

WHO Label

Kappa

B.1.617.1

Pango Lineage

B.1.617.1

VBM

Current Status

VBM

VOI:  May 7, 2021

VBM: September 21, 2021

Date of Designation

VOI:  May 7, 2021

VBM: September 21, 2021

N/A

WHO Label

N/A

B.1.617.3

Pango Lineage

B.1.617.3

VBM

Current Status

VBM

VOI:  May 7, 2021

VBM: September 21, 2021

Date of Designation

VOI:  May 7, 2021

VBM: September 21, 2021

Omicron (parent lineages)**

WHO Label

Omicron (parent lineages)**

B.1.1.529 and descendant lineages

Pango Lineage

B.1.1.529 and descendant lineages

VOC

Current Status

VOC

VOC: November 26, 2021

Date of Designation

VOC: November 26, 2021

Zeta

WHO Label

Zeta

P.2

Pango Lineage

P.2

VBM

Current Status

VBM

VOI:  February 26, 2021

VBM: September 21, 2021

Date of Designation

VOI:  February 26, 2021

VBM: September 21, 2021

Mu

WHO Label

Mu

B.1.621, B.1.621.1

Pango Lineage

B.1.621, B.1.621.1

VBM

Current Status

VBM

VBM: September 21, 2021

Date of Designation

VBM: September 21, 2021

* Many lineages have acquired the F456L mutation and common examples include EG.5, FL.1.5.1, and XBB.1.16.6.

** Omicron parent lineages include BA.1 or similar.

References